Terms ending in 2028
Every in-force patent on Sanofi's record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,833,999 | Tetrahydroisoquinoline Sulfonamide Derivatives, the Preparation Thereof, and the Use of the Same in Therapeutics In force · High confidence | Sanofi | In force | High confidence | |
| US 8,420,805 | Process For Preparing Prophyrin Derivatives, Such As Protoprophyrin (IX) And Synthesis Intermediates In force · High confidence | Sanofi Pasteur S.A. | In force | High confidence | |
| US 8,198,287 | Substituted Heteroaryl Pyridopyrimidone Derivatives In force · High confidence | Sanofi | In force | High confidence | |
| US 8,163,736 | Cytotoxic Agents Comprising New Tomaymycin Derivatives In force · High confidence | Sanofi | In force | High confidence | |
| US 8,404,678 | Cytotoxic Agents Comprising New Tomaymycin Derivatives and Their Therapeutic Use In force · High confidence | Sanofi | In force | High confidence | |
| US 9,370,584 | CA6 Antigen-Specific Cytotoxic Conjugate and Methods of Using the Same In force · High confidence | Sanofi | In force | High confidence | |
| US 8,263,614 | Derivatives of 7-Alkynyl-1,8-Naphthyridones, Preparation Method Thereof and Use of Same in Therapeutics In force · High confidence | Sanofi | In force | High confidence | |
| US 8,980,262 | Humanized ANTI-CXCR5 Antibodies, Derivatives Thereof and Their Use In force · High confidence | Sanofi | In force | High confidence | |
| US 9,175,087 | Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use In force · High confidence | Sanofi | In force | High confidence | |
| US 9,228,019 | Humanized ANTI-CXCR5 Antibodies, Derivatives Thereof and Their Use In force · High confidence | Sanofi | In force | High confidence | |
| 10 more term ends in 2028 · Pro | |||||
10 of 20 patents shown. Soonest term end first, then patent number.
Pro members see all 20, including 2 expiring within the 18 months from Nov 17, 2026.
19 of these are in force and held by Sanofi.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.